Selected Recent Articles
- Methadone Users May Need Education About Hepatitis C Treatment. (September 2016, Hepmag)
- ACLU, Harvard Law Sue Colorado for Restricting Access to Hepatitis C Treatment. (September 2016, Hepmag)
- Hepatitis C Treatment: Getting It and Paying for It. (September 2016, Hepmag)
- U.S. Hepatitis C Population Isn’t Getting the Care It Needs. (September 2016, Hepmag)
- Study Supports Removal of Drug Use as Restriction for Hepatitis C Treatment. (August 2016, Hepmag)
- How Telemedicine Can Bridge the Gaps in Hepatitis C Care. (August 2016, Poz; related coverage in Hepmag)
- HCV Patients Face Obstacles to Treatment. (August 2016, MedPage Today)
- Treating All People With Hepatitis C on Medicaid Would Save Money. (August 2016, Hepmag)
- Curing Hepatitis C Is Cheaper with Harvoni Than with Older Regimens. (July 2016, Hepmag)
- Hepatitis C Treatment Access Is Opening Up Across the Country. (July 2016, Hepmag)
- Telemedicine May Be the Future of Hepatitis C Care. (June 2016, Hepmag)
- Hepatitis C antigen testing could eliminate need for two-step HCV testing, reduce cost of access. (June 2016, AIDSmap)
- Strategies for improving the hepatitis C care continuum for people who inject drugs. (June 2016, CATIE)
- Australia shows an alternative to rationing hepatitis C treatment. (June 2016, AIDSmap)
- Despite New Medi-Cal Rules, Hepatitis C Treatment Is Hard to Come by in California. (June 2016, Hepmag)
- New Funding to Support Curing Hep C Among People of Color Living with HIV. (June 2016, Poz)
- New HCV therapies unaffordable to health systems and individuals. (June 2016, AIDSmap)
- Pricey Hepatitis C Drugs Out of Reach for Many Worldwide. (June 2016, Hepmag)
- Sofosbuvir/ledipasvir regimens can cost less per cure than older hepatitis C treatments. (June 2016, AIDSmap)
- Federal Judge Orders Washington Medicaid to Stop Limiting Hepatitis C Treatment. (June 2016, Hepmag)
- France to provide universal access to hepatitis C treatment. (June 2016, AIDSmap)
- Generic hep C drugs as effective as high-cost brand names, plus other European Liver Conference highlights. (May 2016, Beta Blog)
- Hepatitis C is Killing Americans in Record Numbers While Patients Cannot Access Life Saving Medicine. (May 2016, Hepmag)
- New York Insurers Agree to Ease Restrictions on Hepatitis C Treatment. (May 2016, Hepmag)
- Generic Hepatitis C Drugs Appear Highly Effective. (April 2016, Hepmag)
- New York Attorney General Sues Albany Insurer for Restricting Access to HCV Treatment. (April 2016, Hepmag)
- High Cure Rates Using Generic Hepatitis C Drugs Bought Online: EASL Supports Lower Cost Access for Western Countries. (April 2016, HIV i-base); related coverage from Poz
- $300 hepatitis C combination to enter clinical trials. (April 2016, AIDSmap)
- Identifying People Who Don’t Know They Are Infected with Hepatitis C. (April 2016, Hepmag)
- Coinfection with HIV, HCV may simplify access to antiviral treatment. (April 2016, Healio)
- Low-cost generic hepatitis C drugs match branded products in viral response. (April 2016, AIDSmap)
- Eliminating Hepatitis B & C is Feasible, But What Will it Take to Achieve this Goal? (April 2016, NASTAD)
- Primary care doctors and nurse practitioners can successfully treat people with hepatitis C. (April 2016, AIDSmap); additional related coverage from AIDSmap
- Hepatitis C Tourism Surges Between China and India. (April 2016, Hepmag)
- Delaying Hepatitis C Treatment May Increase Liver-Related Death Risk in Those with HIV. (April 2016, Poz)
- Help Stop Insurers from Over-Charging Patients for Hepatitis B Drugs on the Healthcare Marketplace. (April 2016, Hepmag)
- Harvard Analysis Alleges Health Insurance Discrimination Against People With HIV and Hepatitis C. (April 2016, Poz)
- Accessing the Cure: Helping Patients With Hepatitis C Overcome Barriers to Care. (March 2016, Project Inform)
- Hep C Screening Among Baby Boomers Is Inadequate, And Those With Medicaid Are Less Likely To Be Treated. (March 2016, Hepmag)
- Urban Injection Drug Users Succeed on Hep C Treatment With Hands-On Care Protocol. (March 2016, Poz)
- Kansas Legislators Want No Medicaid for Some with Hepatitis C. (January 2016, Hepmag)
- Private Insurers Denied 1 in 4 Initial Requests for Harvoni in 2015. (January 2016, Hepmag)
- Generic Sovaldi and Daklinza Could Be Made for Just $200 Per Cure. (December 2015, Hepmag)
- DAAs could halt HCV epidemic in US – but only with near-universal testing and big increase in treatment rates. (December 2015, AIDSmap)
- A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir, says US study, but most successfully appeal. (December 2015, AIDSmap)
- A New Look Behind the Pricing of a $1,000 Pill. (December 2015, Hepmag)
- Natco Pharma to Make Generic Daklinza for Hepatitis C. (December 2015, Hepmag)
- U.S. Hepatitis C Costs Fuel 6% Growth in Health Care Spending. (December 2015, Hepmag)
- State Medicaid Restrictions for Hepatitis C Cures Are Creating One of America’s Worst Health Disparities. (December 2015, Hepmag)
- U.S. Senate Report Criticizes Gilead for Hepatitis C Drug Costs. (December 2015, Hepmag)
- Treating Hep C Earlier Is More Cost-Effective. (December 2015, Hepmag)
- ACLU Sues Indiana for Restricting Hepatitis C Treatment. (December 2015, Hepmag)
- BMS Offers Generic Daclatasvir for Hepatitis C in 112 Countries. (December 2015, Hepmag)
- United States faces biggest burden of hepatitis C treatment costs before 2020. (December 2015, AIDSmap)
- Social Security and Medicare Changes for 2016. (December 2015, Poz)
- Insurance Woes. (December 2015, Hepmag)
- Why We Should Be Willing to Pay for Hepatitis C Treatment. (November 2015, Hepmag)
- Class Action Lawsuit Against Blue Cross for Denying Hepatitis C Treatment. (November 2015, Hepmag)
- Hepatitis C Initiative in Ryan White Clinics Findings from a Special Program of National Significance. (November 2015, Hepmag)
- Urgency of Hep C Treatment Rises as Fibrosis Advances. (November 2015, Hepmag)
- Medicare Expected to Spend $9.2B on Hepatitis C Drugs in 2015. (November 2015, Hepmag)
- Almost half of U.S. Medicaid recipients denied funding for hepatitis C treatment, 4-state study shows. (November 2015, AIDSmap)
- Medicaid Disproportionately Denies Hepatitis C Therapy Coverage. (November 2015, Hepmag)
- Express Scripts to Continue With AbbVie Hepatitis C Drugs. (November 2015, Hepmag)
- The Dark Side of Letting Insurance Payers Dictate Hepatitis C Treatment. (November 2015, Hepmag)
- Promising Approaches to Improving Outcomes along the HCV Continuum of Care. (October 2015, Hepmag)
- U.S. study provides ‘real world’ evidence about which patients with hepatitis C should be prioritised for therapy. (October 2015, AIDSmap)
- Interferon-free treatment works well for people who inject drugs, but barriers to access remain. (October 2015, AIDSmap)
- Injection Drug Users With Hep C Should Get Treatment. (October 2015, Hepmag)
- Gilead to Provide Free Hepatitis C Treatment in Iceland. (October 2015, Hepmag)
- People who inject drugs should have access to hepatitis C treatment, expert panel recommends. (October 2015, AIDSmap)
- Florida Insurers Cited for Alleged Hepatitis Discrimination. (October 2015, Hepmag)
- What is the process for new hepatitis drugs to become available at pharmacies after FDA approval? (October 2015, Hepmag)
- Rhode Island Medicaid Denied 65% of Hep C Treatment Requests in 2015. (September 2015, Hepmag)
- Lack of Insurance Impedes Prompt Care After Hep C Diagnosis. (September 2015, Hepmag)
- Medicines Patent Pool to Expand Global Hepatitis C Treatment. (September 2015, Hepmag)
- Experts Urge More Medicaid Access to Hepatitis C Treatment. (September 2015, Hepmag)
- Medicines Patent Pool looks at hepatitis C. (September 2015, AIDSmap)
- Initial Insurance Denials of Hep C Drug Harvoni May Be Reversible. (August 2015, Hepmag)
- The Need for a Codified Hepatitis C Care Continuum. (August 2015, TheBodyPro.
- Concerns Over State Restrictions on New Hepatitis C Drugs. (July 2015, Hepmag)
- China Rejects Patent for Hep C Drug Sovaldi. (June 2015, Hepmag)
- Connecticut Cuts Costs of Hepatitis C Drugs Through Medicaid. (June 2015, Hepmag)
- Veterans Affairs Plans to Outsource Hepatitis C Care. (June 2015, Hepmag)
- Massachusetts Inmates Sue Prisons for Hepatitis C Treatment. (June 2015, Hepmag)
- Hepatitis C Patients Take Extreme Measures for Cheaper Cures. (June 2015, Hepmag)
- Inmates Sue Minnesota for Alleged Denial of Hepatitis C Drugs. (May 2015, Hepmag)
- Sanders Urges Veterans Affairs to Break Hepatitis C Patents. (May 2015, Hepmag)
- World Health Organization Throws Weight Behind Hep C Treatments. (May 2015, Hepmag)
- California Woman Sues Insurer to Pay for Hepatitis C Treatment. (May 2015, Hepmag)
- Hepatitis C treatment for people in prison may be highly cost-effective in England. (May 2015, AIDSmap)
- Curing Hepatitis C Likely Spells Substantial Economic Benefit. (May 2015, Hepmag)
- WHO Adds New Hepatitis C Drugs to Essential Medicines List. (May 2015, Hepmag)
- Another study confirms detrimental effects of delaying hepatitis C treatment. (May 2015, AIDSmap)
- Gilead to Give Country of Georgia Free Hepatitis C Treatment. (April 2015, Hepmag)
- Hepatitis C Treatment Costs Threaten to Cripple Prison Budgets. (April 2015, Hepmag)
- Is There Any Good Reason Left to Delay Hepatitis C Treatment? (April 2015, Hepmag)
- Hep C Treatment Is Sometimes Cost-Effective for Genotypes 2 and 3. (April 2015, Hepmag)
- Medicare Spent $4.5 Billion on New Hepatitis C Drugs in 2014. (April 2015, Hepmag)
- Supervisor Wiener: Reclassifying HIV Drugs as “Specialty” is Discriminatory. (March 2015, Beta Blog)
- A Community-based Program Successfully Engages Participants in Hepatitis C Care. (March 2015, Hepmag)
- Hepatitis C – Both the Good News and Bad. (March 2015, Beta Blog)
- Harvoni Is Mostly Cost Effective, But Budget Impact Will Be Huge. (March 2015, Hepmag)
- $10 Per Pill Unauthorized Generic Sovaldi Being Sold in Bangladesh. (March 2015, Hepmag)
- Pricey New Hep C Drugs Still Cheaper Per Cure Than Oldest Ones. (March 2015, Hepmag)
- Indian Drugmaker Natco to Make Generic Hepatitis C Treatments. (March 2015, Hepmag)
- Advocates Adapt Global HIV Strategy for Cheaper HCV Drugs. (March 2015, Hepmag)
- Delaying Hep C Therapy for HIV/HCV Coinfected People Is Risky. (March 2015, Poz)
- Hepatitis C, the costs of treatment, the costs of delay, and the case for action. (March 2015, Science Speaks Blog)
- Average cost per SVR12 was $171,000 for Olysio, Sovaldi regimens. (March 2015, Healio)
- Delay HCV Tx and Watch Patients Die. (March 2015, MedPage Today)
- Delayed HCV therapy may increase liver-related deaths. (February 2015, Healio)
- People With Hep C May Stick With Meds Better If Care Is Personalized. (February 2015, Hepmag)
- amfAR Report Examines Hepatitis C Drug Pricing Controversy. (February 2015, Hepmag)
- Success for a Program to Help Get People With Hep C Into Care. (February 2015, Hepmag)
- Denied Hepatitis C Treatment? Here is How to Fight Back. (February 2015, Hepmag)
- UnitedHealth Prioritizes Hepatitis C Drug Harvoni. (February 2015, Hepmag)
- FDA Intends to Rescind Breakthrough Status for Merck Hep C Therapy. (February 2015, Hepmag)
- Aetna Gives Priority to Hepatitis C Drugs Sovaldi and Harvoni. (January 2015, Hepmag)
- Indian Manufacturers to Make Cheaper, Generic Sovaldi After Patent Rejection. (January 2015, Hepmag)
- Humana Prioritizes Hepatitis C Drugs Sovaldi and Harvoni. (January 2015, Hepmag)
- Prime Therapeutics Gives Priority to Harvoni and Viekira Pak. (January 2015, Hepmag)
- Hepatitis C Drug Victrelis (Boceprevir) Gets Pulled by Manufacturer. (January 2015, Project Inform)
- ADAP Crisis Task Force Negotiates Discount on Viekira Pak. (January 2015, Hepmag)
- VA and DOD Spent Nearly $500M Treating Hepatitis C in 2014. (January 2015, Hepmag)
- Anthem Also Prioritizes Sovaldi and Harvoni Over Viekira Pak. (January 2015, Hepmag)
- CVS to Prioritize Sovaldi and Harvoni Over Viekira Pak. (January 2015, Hepmag)
- 2014 Viral Hepatitis Year-in-Review and Looking to 2015. (January 2015, Hepmag)
- People With Hepatitis C Often Get Lost in the Health Care Shuffle. (January 2015, Hepmag)
- U.S. Hepatitis C Patients Lost to Care at Different Stages of Care. (December 2014, Hepmag)
- U.S. Congress Meets Again to Discuss Hepatitis C Drug Pricing. (December 2014, Hepmag)
- New HCV Option Effective, Safe, Well-Tolerated – and Use Will Likely Be Driven by Payors. (December 2014, Journal Watch)
- Major Pharmacy Group Will Prioritize AbbVie’s Hep C Regimen. (December 2014, Hepmag)
- One million people with hepatitis C in the US at high priority for treatment. (December 2014, AIDSmap)
- SEPTA Seeks Federal Class Action Lawsuit Over Sovaldi Pricing. (December 2014, Hepmag)
- Hep C Treatment Guidelines Prioritize Care. (December 2014, Hepmag)
- Hep C Hospitalizations and Related Costs Are On the Rise. (December 2014, Hepmag)
- France Secures Lowest Price for Sovaldi in All of Europe. (December 2014, Hepmag)
- US activists called on Gilead to set a per-treatment price for sofosbuvir/ledipasvir. (November-December 2014, HIV Treatment Bulletin)
- What 2014 Development Has the Biggest Impact on HIV Care? (November 2014, TheBodyPro)
- Alleged Misuse of Sovaldi for Hepatitis C Genotype 4 in Egypt. (November 2014, Hepmag)
- The Thorny Economics of Treating Inmates Hep C With Sovaldi. (November 2014, Hepmag)
- Express Scripts May Swap Sovaldi for Cheaper AbbVie Combo. (October 2014, Hepmag)
- Hep C Treatment Guidelines Re-Stress That Treatment Is for All. (October 2014, Hepmag)
- ‘Pay If You Clear’ Program Proposed for Olysio in Scotland. (October 2014, Hepmag)
- Advocates Criticize Plans to Restrict N.Y. Hepatitis C Drugs. (October 2014, Hepmag)
- Fair Pricing Coalition Seeks Uniform Price for Harvoni Treatment. (October 2014, Hepmag)
- Fair Pricing Coalition Welcomes Approval of Gilead Sciences’ Combination Tablet for Hepatitis C, Urges a Uniform Price for Curative Treatment. (October 2014, Fair Pricing Coalition)
- France to Tax Hepatitis C Drug Makers to Encourage Price Cuts. (October 2014, Hepmag)
- Hepatitis C: Treating Those at High Risk. (October 2014, Hepmag)
- Australia Refuses to Subsidize Hepatitis C Sovaldi Treatment. (October 2014, Hepmag)
- Only 10% of veterans with HCV or HCV/HIV in the U.S. treated for HCV. (September/October 2014, HIV Treatment Bulletin)
- Sofosbuvir/Ledipasvir Combo Pill Potentially Pricier Than Sovaldi. (September 2014, Hepmag)
- Indian Drug Makers to Sell Generic Sovaldi to 91 Poor Countries. (September 2014, Hepmag)
- What Kind of Doctor Should You See For Hepatitis C Treatment? (September 2014,Poz)
- Advocates Urge HHS to End Barriers to Hep C Treatment. (September 2014, Hepmag)
- Primary Care Docs Clueless About Hep C Drugs. (September 2014, Hepmag)
- HIV Clinicians Excluded From Prescribing Hepatitis C Treatment. (September 2014, Hepmag)
- ACT UP Letter Asks U.S. Senate to Negotiate Sovaldi Price Cut. (August 2014, Hepmag)
- Hep C Meds Could Increase Federal Medicare Spending $3B by 2015. (August 2014, Hepmag)
- New Hep C Meds Could Spell Disaster for U.S. Prison Budgets. (August 2014, Hepmag)
- Gilead’s Hep C Cure Was Initially Pitched to Be Half the Price. (August 2014, Hepmag)
- U.S. Senate investigate Gilead for sofosbuvir price: potential to bankrupt Federal healthcare and add $300 annually to every American insurance premium for the next five years. (August 2014, HIV i-Base)
- Hep C Drugs Could Add $300 to Everyone’s Yearly Insurance Premium. (July 2014, Hepmag)
- Should Congress Free Medicare to Negotiate Drug Prices? (July 2014, Hepmag)
- U.S. Senate Opens Investigation on Price of Hep C Drug Sovaldi. (July 2014, Poz)
- Gilead Reaps $3.48 Billion in Second Quarter Sovaldi Sales. (July 2014, Poz)
- Just 9 Percent of Americans With Hep C Have Been Cured. (July 2014, Poz)
- New Analysis Identifies Major Gaps in Hep C Health Care. (July 2014, Hepmag)
- The Price of NOT Curing Hepatitis C. (July 2014, Poz)
- Egypt Will Get Sovaldi for $300 Per Treatment. (July 2014, Poz)
- EU Nations Team Up to Lower Price of New Hep C Drug. (July 2014, Poz)
- Push Back Against Expensive Medicines. (July 2014, Hepmag)
- CDC Adopts Health IT, Telemedicine to Combat Hepatitis Epidemic. (June 2014, Hepmag)
- Poll: 75% of Primary Care Docs Unaware of New Hep C Meds. (June 2014, Hepmag)